Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
High-Fidelity Long-Read Sequencing Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The market size for high-fidelity long-read sequencing has witnessed exponential growth in recent years. This market is projected to expand from $1.53 billion in 2025 to $1.88 billion in 2026, achieving a compound annual growth rate (CAGR) of 22.2%. Factors contributing to its historical growth include advancements in sequencing chemistry accuracy, early adoption by genomics research institutions, the broadening of large-scale genome projects, heightened demand for structural variant analysis, and improvements in sequencing hardware performance.
The high-fidelity long-read sequencing market is anticipated to show significant expansion in the coming years. It is projected to achieve a value of $4.22 billion by 2030, growing at a compound annual growth rate (CAGR) of 22.5%. This growth during the forecast period is driven by factors such as the increasing adoption of precision medicine, rising investments in genomics-based drug discovery, the expansion of research into rare diseases, the growing clinical integration of long-read sequencing, and continuous advancements in sequencing cost efficiency. Notable trends for this period include a greater embrace of long-read sequencing in clinical diagnostics, an increasing demand for high-accuracy variant detection, the expanding use of de novo genome assembly techniques, the broadening of epigenetic and transcriptomic analysis applications, and enhanced integration of advanced bioinformatics tools.
Get A Free Sample Report With In-Depth Market Insights:
High-Fidelity Long-Read Sequencing Market Demand Drivers: What’s Powering Industry Growth?
The increasing occurrence of rare diseases is anticipated to fuel the expansion of the HiFi long-read sequencing market in the future. Rare diseases are conditions affecting a small population, typically characterized by intricate symptoms and restricted therapeutic choices. The rise in rare diseases can be attributed to advancements in genetic sequencing and diagnostic techniques, which allow for more timely and precise identification of conditions previously unrecognized or incorrectly categorized. HiFi long-read sequencing assists in tackling rare diseases by providing extremely accurate, extensive detection of intricate genetic variations frequently overlooked by short-read sequencing, resulting in quicker and more accurate diagnoses. For example, in July 2023, data from the Department of Health & Social Care, a UK-based government department, indicated that over 7,000 rare diseases are estimated to exist, with ongoing research continually uncovering new conditions. It is understood that around 80% of these rare diseases are genetically based. Consequently, the growing incidence of rare diseases is stimulating the expansion of the HiFi long-read sequencing market.
High-Fidelity Long-Read Sequencing Market Segment Landscape: Which Areas Lead Development?
The high-fidelity long-read sequencing market covered in this report is segmented –
1) By Product Type: Instruments; Consumables; Software
2) By Sequencing Technology: Single-Molecule Real-Time Sequencing; Nanopore Sequencing; Other Sequencing Technologies
3) By Application: Clinical Diagnostics; Genomics Research; Oncology; Rare Disease Detection; Agriculture And Animal Research; Other Applications
4) By End-User: Academic And Research Institutes; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End-Users
Subsegments:
1) By Instruments: Sequencers; Library Preparation Systems; Sample Preparation Instruments; Data Collection Devices; Quality Control Instruments
2) By Consumables: Sequencing Kits; Flow Cells; Reagents; Pipette Tips; Sample Tubes
3) By Software: Data Analysis Software; Visualization Software; Sequence Alignment Software; Genome Assembly Software; Quality Assessment Software
High-Fidelity Long-Read Sequencing Market Innovation Trends: What Developments Are Reshaping The Industry?
Leading companies within the HiFi long-read sequencing market are prioritizing the development of innovative solutions, such as hybrid-capture target enrichment, to significantly enhance sequencing accuracy, broaden the coverage of complex genomic regions, and accelerate the detection of structural variants for advanced research and clinical applications. Hybrid-capture target enrichment refers to a genomic sequencing method designed to selectively isolate specific regions of DNA or RNA from a sample using complementary probes, thereby allowing for focused, high-accuracy sequencing of target areas while reducing the analysis of non-relevant regions. For example, in July 2025, QIAGEN N.V., a Netherlands-based biotechnology company, launched its QIAseq xHYB Long Read Panels to expand its next-generation sequencing (NGS) offerings. This product employs hybrid-capture enrichment to enable precise long-read sequencing of intricate genomic regions like repeats and structural variants, effectively overcoming limitations associated with short-read technologies. These panels provide superior uniformity, specificity, and complete coverage for uses in cancer profiling, HLA typing, and haplotype phasing, featuring flexible fixed or custom formats and integrated workflows from DNA preparation through bioinformatics analysis, ultimately delivering streamlined efficiency and deeper insights for precision medicine.
High-Fidelity Long-Read Sequencing Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the high-fidelity long-read sequencing market are Azenta Inc., BGI Genomics Co. Ltd., GenScript Biotech Corporation, Novogene Co. Ltd., Takara Bio Inc., Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Inc., MGI Tech Co. Ltd., Discovery Life Sciences Inc., Eurofins Genomics LLC, CD Genomics, BaseClear B.V., Psomagen Inc., Health in Code S.L., Creative Biogene Inc., Nucleome Informatics Private Limited, Genevia Technologies Oy, JS Link Co. Ltd., SeqCenter LLC, Theragen Bio Co. Ltd.
View The Full High-Fidelity Long-Read Sequencing Market Report:
High-Fidelity Long-Read Sequencing Market Geographic Spread And Regional Opportunities
North America was the largest region in the HiFi long-read sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high-fidelity long-read sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model